Why the study?
The study evaluated the prognostic value and incremental predictive utility of NAFLD for MACE in patients with suspected CAD evaluated by CCTA and CT-FFR.
Does the presence of NAFLD predict major adverse cardiovascular events in patients with suspected coronary artery disease?
Population
2,981 patients with suspected CAD undergoing CCTA and non-contrast liver/spleen CT
Comparison
NAFLD vs non-NAFLD
Design
Retrospective single-centre cohort study
Follow-up
Median 68-month
Authors
Loading...
May enhance MACE risk stratification in suspected CAD; hypothesis-generating, requiring prospective validation before practice change.
Does the presence of NAFLD predict major adverse cardiovascular events in patients with suspected coronary artery disease?
The presence of NAFLD independently predicts major adverse cardiovascular events in patients with suspected CAD and improves risk stratification beyond traditional risk factors and CCTA findings.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: